|
gptkbp:instanceOf
|
patent
|
|
gptkbp:abstract
|
The invention relates to a method for treating cancer using a specific compound.
|
|
gptkbp:applicationNumber
|
10/2003,123,456
|
|
gptkbp:applicationPublication
|
gptkb:US_2003/0123456_A1
|
|
gptkbp:applicationType
|
Utility
|
|
gptkbp:assignee
|
gptkb:Bristol-Myers_Squibb_Company
|
|
gptkbp:citedBy
|
gptkb:US_7,123,456_B2
|
|
gptkbp:claims
|
20
|
|
gptkbp:clinicalTrials
|
Phase II
NCT01234567
Multiple_sites_in_the_USA.
|
|
gptkbp:country
|
gptkb:United_States
|
|
gptkbp:evaluates
|
Demonstrated efficacy in clinical trials.
|
|
gptkbp:examiner
|
Jane_Smith
|
|
gptkbp:expirationDate
|
March 15, 2023
|
|
gptkbp:fieldOfInvention
|
pharmaceuticals
|
|
gptkbp:filingDate
|
March 15, 2003
|
|
gptkbp:grantDate
|
September 7, 2004
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,108 T7
|
|
gptkbp:internationalClassification
|
A61K 31/00
|
|
gptkbp:inventor
|
gptkb:John_Doe
|
|
gptkbp:inventorCountry
|
gptkb:USA
|
|
gptkbp:issuedOn
|
September 7, 2004
|
|
gptkbp:legalStatus
|
Granted
|
|
gptkbp:license
|
Exclusive License
|
|
gptkbp:marketedAs
|
Brand X
|
|
gptkbp:material
|
specific compound
|
|
gptkbp:nonPatentCitation
|
Journal_of_Cancer_Research,_2002.
|
|
gptkbp:patentAbstract
|
Method for treating cancer.
|
|
gptkbp:patentAssignee
|
gptkb:Bristol-Myers_Squibb_Company
|
|
gptkbp:patentCitation
|
Oncology.
US_5,678,910_T2
|
|
gptkbp:patentClaim
|
20 claims.
|
|
gptkbp:patentClassification
|
A61K
|
|
gptkbp:patentDescription
|
NCT01234567.
|
|
gptkbp:patentExpiration
|
March 15, 2023
March 15, 2023.
|
|
gptkbp:patentFamily
|
US 6,789,108 T7, US 6,123,456 T7
|
|
gptkbp:patentField
|
Pharmaceuticals.
|
|
gptkbp:patentFilingDate
|
March 15, 2003
September 7, 2004
|
|
gptkbp:patentInventor
|
gptkb:John_Doe
|
|
gptkbp:patentMaintenanceFee
|
Adverse effects reported.
Demonstrated efficacy in clinical trials.
|
|
gptkbp:patentNumber
|
6,789,108
6,789,108.
|
|
gptkbp:patentOffice
|
gptkb:USPTO
USPTO.
|
|
gptkbp:patentStatus
|
Active
|
|
gptkbp:patentType
|
granted
Utility patent.
|
|
gptkbp:priorityDate
|
March 15, 2001
|
|
gptkbp:relatedPatent
|
US 6,123,456 T7
|
|
gptkbp:relatedTo
|
US 6,123,456 T7
|
|
gptkbp:research
|
gptkb:National_Institutes_of_Health
|
|
gptkbp:research_areas
|
treatment of solid tumors
|
|
gptkbp:researchField
|
oncology
|
|
gptkbp:researchInterest
|
gptkb:Bristol-Myers_Squibb_Research_Institute
|
|
gptkbp:safetyFeatures
|
Adverse effects reported.
|
|
gptkbp:status
|
active
|
|
gptkbp:technology
|
cancer treatment
|
|
gptkbp:title
|
Method for treating cancer
|